AHMED NADIM

Chairman & CEO

C-suiteM

US·SEC (Form 4)

Cullinan Oncology, Inc.

0

Total declarations

0

Company

€93,829

▲ Purchases (1 ops.)

—

▼ Sales (0 ops.)

Browse the full record of transactions filed by AHMED NADIM, Chairman & CEO. Insider active across 1 companies, notably Cullinan Oncology, Inc.. Aggregated, 1 filings have been logged. Total volume traded: €94k. The latest transaction was disclosed on 6 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.

Declarations1 total

Executives▲PurchaseCCullinan Oncology, Inc.◆Signal · 55SEC

A

AHMED NADIMPresident and CEO

€93,8298,090 shares@ €11.59810.0097% mcap100.0% of flow

Common Stock

SEC:0000899243-22-021346:0·6 Jun 2022

Ideal exit: 3 Mar 2023 (T+270)

SEC ↗

1 of 1 declaration

About AHMED NADIM

Nadim Ahmed is the Chairman & CEO of Cullinan Oncology, Inc. He is responsible for the strategic direction of the company and the management of its operations. Nadim brings expertise in business development and innovation to support the company's growth.